Fermented Nutritional Yeast Protein

About

What it is and where it shows up.

Fermented nutritional yeast protein is a protein-rich biomass derived primarily from the aerobic propagation and anaerobic fermentation of Saccharomyces cerevisiae (or related yeast species such as Yarrowia lipolytica), which is subsequently dried and deactivated for use as a food ingredient; it provides a complete amino acid profile along with B-vitamins and trace minerals. It is used as a sustainable protein source in foods, dietary supplements, protein bars, beverages, and plant-based formulations.

Safety summary

The regulatory and scientific consensus.

Saccharomyces cerevisiae yeast protein holds GRAS status in the United States and is classified under EFSA's Qualified Presumption of Safety (QPS) framework, reflecting a long history of safe use in food production spanning over 5,000 years. Brewer's yeast-based supplements may contain trace contamination with ochratoxin A, and the high nucleic acid/purine content may be problematic for individuals with gout or hyperuricemia. Sensitive populations — including pregnant women, children, the elderly, and immunocompromised individuals — should exercise caution due to the potential for sporadic mycotoxin formation during processing, and the ingredient is explicitly excluded from infant formula under FDA GRAS conditions.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
Health Canada (Canada)	Approved	Health Canada and Environment and Climate Change Canada 2022 CEPA screening assessment (CAS 8013-01-2) concluded that yeast extract and protein derivatives do not meet section 64 criteria for danger to human life or health. Between 100,000 kg and 1,000,000 kg of yeast extract (including protein fraction) is imported annually in Canada for food, beverage, and nutritional uses.source
EFSA (European Food Safety Authority) (European Union)	Approved	S. cerevisiae holds Qualified Presumption of Safety (QPS) status from EFSA for use throughout the food and feed chain; EFSA confirmed the species is not pathogenic and suitable for QPS safety assessment. Y. lipolytica yeast biomass enriched with selenium was authorized as a novel food supplement under Commission Regulation (EU) 2020/1999. Protein preparations from novel or GMM yeast strains require pre-market EFSA risk assessment under Regulation (EU) 2015/2283 on novel foods.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Yeast and like products fall under FSSAI food category 12.8; protein products other than from soybeans are listed under category 12.10. No dedicated standalone standard exists for fermented nutritional yeast protein. Novel or non-specified yeast protein ingredients must obtain product approval under FSS (Non-Specified Food and Food Ingredients) Regulations, 2017, and are governed by the FSS Act 2006.source

Who should approach with care

Whose guidance would steer them away.

Infants — FDA's GRAS approval for dried yeast fermentate (GRN 000928) explicitly excludes use in infant formula, as safety for this population has not been established.

Other — Individuals with known yeast allergy or hypersensitivity to S. cerevisiae proteins may experience allergic reactions, as yeast protein biomass can trigger immune responses in sensitized individuals.

Gout — Yeast protein biomass is inherently high in nucleic acids and purines, which are metabolized to uric acid; excessive intake may exacerbate hyperuricemia and precipitate gout attacks.

Pregnancy — Brewer's yeast-based supplements have been documented to contain ochratoxin A contamination, and sporadic mycotoxin formation during processing poses additional risk; pregnant women should select only products from rigorously quality-controlled manufacturers.

Children — Children are identified in published safety literature as a sensitive population at heightened risk from potential sporadic mycotoxin contamination and toxic metabolites arising from unskillful processing of yeast biomass.

Research citations

The sources behind this verdict.

1EFSA. Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae CNCM I-1079 for ruminants and camelids (EFSA FEEDAP Panel, 2022), 2022. pmc.ncbi.nlm.nih.gov
2other. Screening Assessment – Protein Derivatives and Yeast Extract (CAS 8013-01-2, 9015-54-7), 2022. canada.ca
3PubMed. Global Regulatory Frameworks for Fermented Foods: A Review, 2022. pmc.ncbi.nlm.nih.gov
4PubMed. Yeast Protein as an Easily Accessible Food Source, 2022. pmc.ncbi.nlm.nih.gov
5FDA. Agency Response Letter GRAS Notice No. GRN 000928 – Dried Saccharomyces cerevisiae Yeast Fermentate (Cargill, Inc.), 2021. fda.gov

Independently researched5 citations